{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:59:18Z","timestamp":1771981158336,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","award":["Global Fund to Fight AIDS, Tuberculosis and Malaria"],"award-info":[{"award-number":["Global Fund to Fight AIDS, Tuberculosis and Malaria"]}],"id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s13258-025-01726-8","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T07:38:38Z","timestamp":1766821118000},"page":"383-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of germline 113 cancer genes in healthy Indonesian hospital staff"],"prefix":"10.1007","volume":"48","author":[{"given":"Mega","family":"Hayati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahreza","family":"Saputra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubertus Hosti","family":"Hayuanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyana","family":"Setiawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Rusdan H.","family":"Utomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"1726_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13073-019-0691-1\/TABLES\/4","volume":"12","author":"NS Abul-Husn","year":"2019","unstructured":"Abul-Husn NS, Soper ER, Odgis JA et al (2019) Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank. Genome Med 12:1\u201312. https:\/\/doi.org\/10.1186\/S13073-019-0691-1\/TABLES\/4","journal-title":"Genome Med"},{"key":"1726_CR2","doi-asserted-by":"publisher","unstructured":"Adam K, Wibowo HA, Adelina R et al (2020) BRCA 1 and BRCA 2 gene sequencing in Indonesian urban women: further study of noncommunicable disease research 2016. 563\u2013567. https:\/\/doi.org\/10.2991\/AHSR.K.200215.109","DOI":"10.2991\/AHSR.K.200215.109"},{"key":"1726_CR3","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1111\/IJD.16138","volume":"61","author":"H Albela","year":"2022","unstructured":"Albela H, Ngu LH, Leong KF (2022) Xeroderma pigmentosum in a Malaysian child with identification of a novel homozygous nonsense mutation in XPC c.2167C\u2009>\u2009T. Int J Dermatol 61:e324\u2013e326. https:\/\/doi.org\/10.1111\/IJD.16138","journal-title":"Int J Dermatol"},{"key":"1726_CR4","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.7314\/APJCP.2016.17.4.1987","volume":"17","author":"SL Anwar","year":"2016","unstructured":"Anwar SL, Haryono SJ, Aryandono T, Datasena IGB (2016) Screening of BRCA1\/2 mutations using direct sequencing in Indonesian familial breast cancer cases. Asian Pac J Cancer Prev 17:1987\u20131991. https:\/\/doi.org\/10.7314\/APJCP.2016.17.4.1987","journal-title":"Asian Pac J Cancer Prev"},{"key":"1726_CR5","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/S41416-024-02827-Z;SUBJMETA","volume":"131","author":"B Arun","year":"2024","unstructured":"Arun B, Couch FJ, Abraham J et al (2024) BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing. Br J Cancer 131:1400\u20131414. https:\/\/doi.org\/10.1038\/S41416-024-02827-Z;SUBJMETA","journal-title":"Br J Cancer"},{"key":"1726_CR6","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.2147\/JMDH.S458564","volume":"17","author":"Y Ausi","year":"2024","unstructured":"Ausi Y, Barliana MI, Postma MJ, Suwantika AA (2024) One step ahead in realizing pharmacogenetics in Low-and Middle-Income countries: what should we do? J Multidiscip Healthc 17:4863\u20134874. https:\/\/doi.org\/10.2147\/JMDH.S458564","journal-title":"J Multidiscip Healthc"},{"issue":"2","key":"1726_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41431-020-00755-z","volume":"29","author":"D Baux","year":"2020","unstructured":"Baux D, Van Goethem C, Ardouin O et al (2020) MobiDetails: online DNA variants interpretation. Eur J Hum Genet 2020 29(2):356\u2013360. https:\/\/doi.org\/10.1038\/s41431-020-00755-z","journal-title":"Eur J Hum Genet 2020"},{"key":"1726_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/S00438-025-02295-X","volume":"300","author":"BCF Bianco","year":"2025","unstructured":"Bianco BCF, Planello AC (2025) Variant classification of hereditary cancer genes is affected by genomic underrepresentation of admixed populations. Mol Genet Genomics 300:86. https:\/\/doi.org\/10.1007\/S00438-025-02295-X","journal-title":"Mol Genet Genomics"},{"key":"1726_CR9","doi-asserted-by":"publisher","first-page":"102785","DOI":"10.1016\/J.CTRV.2024.102785\/ASSET\/CD682792-273B-4457-AEF6-778CEFE2E9F1\/MAIN.ASSETS\/GR2.JPG","volume":"129","author":"A Calabrese","year":"2024","unstructured":"Calabrese A, von Arx C, Tafuti AA et al (2024) Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1\/2 genes. Cancer Treat Rev 129:102785. https:\/\/doi.org\/10.1016\/J.CTRV.2024.102785\/ASSET\/CD682792-273B-4457-AEF6-778CEFE2E9F1\/MAIN.ASSETS\/GR2.JPG","journal-title":"Cancer Treat Rev"},{"key":"1726_CR10","doi-asserted-by":"publisher","first-page":"30649","DOI":"10.18632\/ONCOTARGET.25769","volume":"9","author":"GHJ Chan","year":"2018","unstructured":"Chan GHJ, Ong PY, Low JJH et al (2018) Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers. Oncotarget 9:30649\u201330660. https:\/\/doi.org\/10.18632\/ONCOTARGET.25769","journal-title":"Oncotarget"},{"key":"1726_CR11","doi-asserted-by":"publisher","unstructured":"Chan SH, Ni Y, Li ST et al (2021) Spectrum of germline mutations within fanconi anemia\u2013associated genes across populations of varying ancestry. JNCI Cancer Spectr 5. https:\/\/doi.org\/10.1093\/JNCICS\/PKAA117","DOI":"10.1093\/JNCICS\/PKAA117"},{"key":"1726_CR12","doi-asserted-by":"publisher","first-page":"e2339571","DOI":"10.1001\/JAMANETWORKOPEN.2023.39571","volume":"6","author":"E Chen","year":"2023","unstructured":"Chen E, Facio FM, Aradhya KW et al (2023) Rates and classification of variants of uncertain significance in hereditary disease genetic testing. JAMA Netw Open 6:e2339571. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2023.39571","journal-title":"JAMA Netw Open"},{"key":"1726_CR13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/JNCI\/DJAB036","volume":"113","author":"MM De Jonge","year":"2021","unstructured":"De Jonge MM, De Kroon CD, Jenner DJ et al (2021) Endometrial cancer risk in women with germline BRCA1 or BRCA2 mutations: multicenter cohort study. JNCI: J Natl Cancer Inst 113:1203\u20131211. https:\/\/doi.org\/10.1093\/JNCI\/DJAB036","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"8 22","key":"1726_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ejhg.2013.278","volume":"22","author":"E Degrolard-Courcet","year":"2013","unstructured":"Degrolard-Courcet E, Sokolowska J, Padeano MM et al (2013) Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1\/BRCA2 gene. Eur J Hum Genet 2014 22(8 22):979\u2013987. https:\/\/doi.org\/10.1038\/ejhg.2013.278","journal-title":"Eur J Hum Genet 2014"},{"key":"1726_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jmedgenet-2020-106970","volume":"58","author":"H Dong","year":"2021","unstructured":"Dong H, Chandratre K, Qin Y et al (2021) Prevalence of BRCA1 \/ BRCA2 pathogenic variation in Chinese Han population. J Med Genet 58:565\u2013569. https:\/\/doi.org\/10.1136\/jmedgenet-2020-106970","journal-title":"J Med Genet"},{"key":"1726_CR16","unstructured":"Dwyer M (2025) NCCN clinical practice guidelines in oncology (NCCN Guidelines \u00ae) Genetic\/familial high-risk assessment: breast, ovarian, pancreatic, and prostate. https:\/\/www.logan.org\/wp-content\/uploads\/2024\/09\/genetics_bop.pdf"},{"key":"1726_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1590\/1678-4685-GMB-2014-0362","volume":"39","author":"M Fl\u00f3ria-Santos","year":"2016","unstructured":"Fl\u00f3ria-Santos M, Lopes-J\u00fanior LC, de Alvarenga L M, et al (2016) Self-reported cancer family history is a useful tool for identification of individuals at risk of hereditary cancer predisposition syndrome at primary care centers in middle-income settings: a longitudinal study. Genet Mol Biol 39:178. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2014-0362","journal-title":"Genet Mol Biol"},{"key":"1726_CR18","doi-asserted-by":"publisher","first-page":"340287","DOI":"10.3389\/FGENE.2018.00188\/BIBTEX","volume":"9","author":"E Fraile-Bethencourt","year":"2018","unstructured":"Fraile-Bethencourt E, Valenzuela-Palomo A, D\u00edez-G\u00f3mez B et al (2018) Identification of eight spliceogenic variants in BRCA2 exon 16 by minigene assays. Front Genet 9:340287. https:\/\/doi.org\/10.3389\/FGENE.2018.00188\/BIBTEX","journal-title":"Front Genet"},{"key":"1726_CR19","unstructured":"Garrett A, Allen S, Loong L et al (2024) CanVIG-UK consensus specification for cancer susceptibility genes (CSGs) of ACGS best practice guidelines for variant classification. https:\/\/060633f9-3751-414a-94b5-69cfb74f02dd.filesusr.com\/ugd\/ed948a_ca951fe798294f7f8545d99ec0909e35.pdf"},{"key":"1726_CR20","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.clbc.2016.08.002","volume":"17","author":"M Ghilli","year":"2017","unstructured":"Ghilli M, Mariniello DM, Fanelli G et al (2017) Carcinosarcoma of the breast: an aggressive subtype of metaplastic cancer. Report of a rare case in a young BRCA-1 mutated woman. Clin Breast Cancer 17:e31\u2013e35. https:\/\/doi.org\/10.1016\/j.clbc.2016.08.002","journal-title":"Clin Breast Cancer"},{"key":"1726_CR21","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/HUMU.23642","volume":"39","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Harrison SM, Rehm HL et al (2018) Updated recommendation for the benign stand alone ACMG\/AMP criterion. Hum Mutat 39:1525. https:\/\/doi.org\/10.1002\/HUMU.23642","journal-title":"Hum Mutat"},{"key":"1726_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/JMG-2022-108898","volume":"60","author":"H Hanson","year":"2023","unstructured":"Hanson H, Kulkarni A, Loong L et al (2023) UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2. J Med Genet 60:417\u2013429. https:\/\/doi.org\/10.1136\/JMG-2022-108898","journal-title":"J Med Genet"},{"key":"1726_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.33371\/ijoc.v19i1.1255","volume":"19","author":"WA Harahap","year":"2025","unstructured":"Harahap WA, Khambri D, Panigoro SS, Hafiz MZA (2025) Mutation of BRCA1\/2 gene in premenopausal triple-negative breast cancer patients in West Sumatera. Indonesian J Cancer 19:72\u201379. https:\/\/doi.org\/10.33371\/ijoc.v19i1.1255","journal-title":"Indonesian J Cancer"},{"key":"1726_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/S10620-024-08282-3","volume":"69","author":"FD Huang","year":"2024","unstructured":"Huang FD, Zhong YP, Sun GY et al (2024) Fanconi anemia complementary group A (FANCA) facilitates the occurrence and progression of liver hepatocellular carcinoma. Dig Dis Sci 69:1035\u20131054. https:\/\/doi.org\/10.1007\/S10620-024-08282-3","journal-title":"Dig Dis Sci"},{"key":"1726_CR25","doi-asserted-by":"publisher","first-page":"102159","DOI":"10.1016\/j.eclinm.2023.102159","volume":"64","author":"L Jackson","year":"2023","unstructured":"Jackson L, Weedon MN, Green HD et al (2023) Influence of family history on penetrance of hereditary cancers in a population setting. EClinicalMedicine 64:102159. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102159","journal-title":"EClinicalMedicine"},{"key":"1726_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/S41523-020-0163-1","volume":"6","author":"T Kaneyasu","year":"2020","unstructured":"Kaneyasu T, Mori S, Yamauchi H et al (2020) Prevalence of disease-causing genes in Japanese patients with BRCA1\/2-wildtype hereditary breast and ovarian cancer syndrome. NPJ Breast Cancer 6:25. https:\/\/doi.org\/10.1038\/S41523-020-0163-1","journal-title":"NPJ Breast Cancer"},{"key":"1726_CR27","doi-asserted-by":"publisher","first-page":"w20092","DOI":"10.4414\/SMW.2019.20092","volume":"149","author":"D Kraemer","year":"2019","unstructured":"Kraemer D, Azzarello-Burri S, Steindl K et al (2019) Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a swiss single centre cohort. Swiss Med Wkly 149:w20092\u2013w20092. https:\/\/doi.org\/10.4414\/SMW.2019.20092","journal-title":"Swiss Med Wkly"},{"key":"1726_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/NG.893","volume":"43","author":"C Loveday","year":"2011","unstructured":"Loveday C, Turnbull C, Ramsay E et al (2011) Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet 43:879\u2013882. https:\/\/doi.org\/10.1038\/NG.893","journal-title":"Nat Genet"},{"key":"1726_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/S12282-020-01121-Z\/METRICS","volume":"27","author":"SS Malik","year":"2020","unstructured":"Malik SS, Zia A, Rashid S et al (2020) XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis. Breast Cancer 27:1168\u20131176. https:\/\/doi.org\/10.1007\/S12282-020-01121-Z\/METRICS","journal-title":"Breast Cancer"},{"key":"1726_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.gim.2021.08.013","volume":"24","author":"LJ McReynolds","year":"2022","unstructured":"McReynolds LJ, Giri N, Leathwood L et al (2022) Risk of cancer in heterozygous relatives of patients with Fanconi anemia. Genet Sci 24:245\u2013250. https:\/\/doi.org\/10.1016\/j.gim.2021.08.013","journal-title":"Genet Sci"},{"key":"1726_CR31","doi-asserted-by":"crossref","unstructured":"Menezes MCS, Raheem F, Mina L et al (2022) PARP inhibitors for breast cancer: germline BRCA1\/2 and beyond. Cancers (Basel, p 14","DOI":"10.3390\/cancers14174332"},{"key":"1726_CR32","doi-asserted-by":"publisher","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT et al (2018) Germline pathogenic variants of 11 breast cancer genes in 7051 Japanese patients and 11,241 controls. Nat Commun 9. https:\/\/doi.org\/10.1038\/S41467-018-06581-8","DOI":"10.1038\/S41467-018-06581-8"},{"key":"1726_CR33","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.7314\/APJCP.2016.17.3.1539","volume":"17","author":"FE Mundhofir","year":"2016","unstructured":"Mundhofir FE, Wulandari CE, Prajoko YW, Winarni TI (2016) BRCA1 gene mutation screening for the hereditary breast and\/or ovarian cancer syndrome in breast cancer cases: a first high resolution DNA melting analysis in Indonesia. Asian Pac J Cancer Prev 17:1539\u20131546. https:\/\/doi.org\/10.7314\/APJCP.2016.17.3.1539","journal-title":"Asian Pac J Cancer Prev"},{"key":"1726_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/NRC.2017.116;SUBJMETA","volume":"18","author":"G Nalepa","year":"2018","unstructured":"Nalepa G, Clapp DW (2018) Fanconi anaemia and cancer: an intricate relationship. Nat Rev Cancer 18:168\u2013185. https:\/\/doi.org\/10.1038\/NRC.2017.116;SUBJMETA","journal-title":"Nat Rev Cancer"},{"key":"1726_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/S10689-019-00144-6\/METRICS","volume":"18","author":"MK Ndugga-Kabuye","year":"2019","unstructured":"Ndugga-Kabuye MK, Issaka RB (2019) Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European. Fam Cancer 18:465\u2013469. https:\/\/doi.org\/10.1007\/S10689-019-00144-6\/METRICS","journal-title":"Fam Cancer"},{"key":"1726_CR36","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1017\/S0016672320000075","volume":"102","author":"T Nguyen-Dumont","year":"2020","unstructured":"Nguyen-Dumont T, Karpinski P, Sasiadek MM et al (2020) Genetic testing in Poland and ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer? Genet Res (Camb) 102:e6. https:\/\/doi.org\/10.1017\/S0016672320000075","journal-title":"Genet Res (Camb)"},{"key":"1726_CR37","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/GIM.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M et al (2017) Sherloc: a comprehensive refinement of the ACMG\u2013AMP variant classification criteria. Genet Sci 19:1105. https:\/\/doi.org\/10.1038\/GIM.2017.37","journal-title":"Genet Sci"},{"key":"1726_CR38","doi-asserted-by":"publisher","first-page":"e0213746","DOI":"10.1371\/JOURNAL.PONE.0213746","volume":"14","author":"SGW Ow","year":"2019","unstructured":"Ow SGW, Ong PY, Lee SC (2019) Discoveries beyond BRCA1\/2: multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world. PLoS ONE 14:e0213746. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0213746","journal-title":"PLoS ONE"},{"key":"1726_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10549-006-9493-4","volume":"106","author":"D Purnomosari","year":"2007","unstructured":"Purnomosari D, Pals G, Wahyono A et al (2007) BRCA1 and BRCA2 germline mutation analysis in the Indonesian population. Breast Cancer Res Treat 106:297\u2013304. https:\/\/doi.org\/10.1007\/s10549-006-9493-4","journal-title":"Breast Cancer Res Treat"},{"key":"1726_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/HUMU.23406","volume":"39","author":"TR Rebbeck","year":"2018","unstructured":"Rebbeck TR, Friebel TM, Friedman E et al (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593. https:\/\/doi.org\/10.1002\/HUMU.23406","journal-title":"Hum Mutat"},{"key":"1726_CR41","doi-asserted-by":"publisher","first-page":"e1011265","DOI":"10.1371\/JOURNAL.PGEN.1011265","volume":"20","author":"JP Sagun","year":"2024","unstructured":"Sagun JP, Khan SG, Imoto K et al (2024) Different germline variants in the XPA gene are associated with severe, intermediate, or mild neurodegeneration in xeroderma pigmentosum patients. PLoS Genet 20:e1011265. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1011265","journal-title":"PLoS Genet"},{"key":"1726_CR42","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-16-2568","volume":"77","author":"H Shimelis","year":"2017","unstructured":"Shimelis H, Mesman RLS, Von Nicolai C et al (2017) BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res 77:2789\u20132799. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2568","journal-title":"Cancer Res"},{"key":"1726_CR43","doi-asserted-by":"publisher","first-page":"617351","DOI":"10.1155\/2014\/617351","volume":"2014","author":"K Shinmura","year":"2014","unstructured":"Shinmura K, Goto M, Tao H et al (2014) Impaired 8-Hydroxyguanine repair activity of MUTYH variant p.Arg109Trp found in a Japanese patient with early-onset colorectal cancer. Oxid Med Cell Longev 2014:617351. https:\/\/doi.org\/10.1155\/2014\/617351","journal-title":"Oxid Med Cell Longev"},{"key":"1726_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/S10549-021-06095-W","volume":"186","author":"J Sukumar","year":"2021","unstructured":"Sukumar J, Kassem M, Agnese D et al (2021) Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series. Breast Cancer Res Treat 186:569\u2013575. https:\/\/doi.org\/10.1007\/S10549-021-06095-W","journal-title":"Breast Cancer Res Treat"},{"key":"1726_CR45","doi-asserted-by":"publisher","first-page":"860","DOI":"10.58631\/AJHS.V2I11.85","volume":"2","author":"S Susanti","year":"2023","unstructured":"Susanti S, Bakhtiar HS, Prasetyo H (2023) Protection of genetic data in health services based on genomics technology in Indonesia. Asian J Healthy Sci 2:860\u2013870. https:\/\/doi.org\/10.58631\/AJHS.V2I11.85","journal-title":"Asian J Healthy Sci"},{"key":"1726_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R et al (2016) Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Sci 18:823\u2013832. https:\/\/doi.org\/10.1038\/gim.2015.166","journal-title":"Genet Sci"},{"key":"1726_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/20503121241299849\/SUPPL_FILE\/SJ-DOCX-1-SMO-10.1177_20503121241299849.DOCX","author":"S Sutrisno","year":"2024","unstructured":"Sutrisno S, Marlina D, Tjandraprawira KD, Adinda Adriansyah PN (2024) The impact of pathogenic BRCA1\/2 tumor mutation status on high grade serous epithelial ovarian cancer survival outcome: a multicenter study from Indonesia. SAGE Open Med. https:\/\/doi.org\/10.1177\/20503121241299849\/SUPPL_FILE\/SJ-DOCX-1-SMO-10.1177_20503121241299849.DOCX. 12:","journal-title":"SAGE Open Med"},{"key":"1726_CR48","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1158\/2643-3230.BCD-23-0208\/748407\/","volume":"5","author":"S Thibaud","year":"2024","unstructured":"Thibaud S, Subaran RL, Newman S et al (2024) Multiple myeloma risk and outcomes are associated with pathogenic germline variants in DNA repair genes. Blood Cancer Discov 5:428\u2013441. https:\/\/doi.org\/10.1158\/2643-3230.BCD-23-0208\/748407\/AM\/MULTIPLEMYELOMA-RISK-AND-OUTCOMES-ARE-ASSOCIATED","journal-title":"Blood Cancer Discov"},{"key":"1726_CR49","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","volume":"34","author":"ER Thompson","year":"2016","unstructured":"Thompson ER, Rowley SM, Li N et al (2016) Panel testing for Familial breast cancer: calibrating the tension between research and clinical care. J Clin Oncol 34:1455\u20131459. https:\/\/doi.org\/10.1200\/JCO.2015.63.7454","journal-title":"J Clin Oncol"},{"key":"1726_CR50","doi-asserted-by":"publisher","first-page":"e1526","DOI":"10.1002\/ONCO.13829","volume":"26","author":"MR Toh","year":"2021","unstructured":"Toh MR, Ngeow J (2021) Homologous recombination deficiency: cancer predispositions and treatment implications. Oncologist 26:e1526\u2013e1537. https:\/\/doi.org\/10.1002\/ONCO.13829;WEBSITE:WEBSITE:THEONCOLOGIST;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Oncologist"},{"key":"1726_CR51","doi-asserted-by":"publisher","first-page":"e247811","DOI":"10.1001\/JAMANETWORKOPEN.2024.7811","volume":"7","author":"S Torres-Esquius","year":"2024","unstructured":"Torres-Esquius S, Llop-Guevara A, Guti\u00e9rrez-Enr\u00edquez S et al (2024) Prevalence of homologous recombination deficiency among patients with germline RAD51C\/D breast or ovarian cancer. JAMA Netw Open 7:e247811\u2013e247811. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2024.7811","journal-title":"JAMA Netw Open"},{"key":"1726_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.ANNONC.2025.04.012\/ATTACHMENT\/7D4AA136-804D-468B-B767-D390DE42787D\/MMC1.DOCX","volume":"0","author":"C Turnbull","year":"2025","unstructured":"Turnbull C, Achatz MI, Balma\u00f1a J et al (2025) Breast cancer germline multigene panel testing in mainstream oncology based on clinical\u2013public health utility: ESMO precision oncology working group recommendations. Ann Oncol 0:27. https:\/\/doi.org\/10.1016\/J.ANNONC.2025.04.012\/ATTACHMENT\/7D4AA136-804D-468B-B767-D390DE42787D\/MMC1.DOCX","journal-title":"Ann Oncol"},{"key":"1726_CR53","first-page":"233","volume":"101","author":"USPSTF","year":"2020","unstructured":"USPSTF (2020) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: recommendation statement. Am Fam Physician 101:233\u2013238","journal-title":"Am Fam Physician"},{"key":"1726_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/J.JNCC.2022.12.001","volume":"3","author":"SM Wang","year":"2022","unstructured":"Wang SM (2022) A global perspective on the ethnic-specific BRCA variation and its implication in clinical application. J Natl Cancer Cent 3:14. https:\/\/doi.org\/10.1016\/J.JNCC.2022.12.001","journal-title":"J Natl Cancer Cent"},{"key":"1726_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/J.JNCC.2022.12.001","volume":"3","author":"SM Wang","year":"2023","unstructured":"Wang SM (2023) A global perspective on the ethnic-specific BRCA variation and its implication in clinical application. J Natl Cancer Cent 3:14\u201320. https:\/\/doi.org\/10.1016\/J.JNCC.2022.12.001","journal-title":"J Natl Cancer Cent"},{"key":"1726_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/JMEDGENET-2017-104947","volume":"55","author":"WX Wen","year":"2018","unstructured":"Wen WX, Allen J, Lai KN et al (2018) Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia. J Med Genet 55:97\u2013103. https:\/\/doi.org\/10.1136\/JMEDGENET-2017-104947","journal-title":"J Med Genet"},{"key":"1726_CR57","doi-asserted-by":"publisher","unstructured":"Woodward ER, Meyer S (2021) Fanconi Anaemia, childhood cancer and the BRCA Genes. Genes 2021. 12:1520. https:\/\/doi.org\/10.3390\/GENES12101520","DOI":"10.3390\/GENES12101520"},{"key":"1726_CR58","doi-asserted-by":"publisher","unstructured":"Wu Z, Zhang Q, Jin Y et al (2024) Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area. BMC Cancer 24. https:\/\/doi.org\/10.1186\/s12885-024-12089-w","DOI":"10.1186\/s12885-024-12089-w"},{"key":"1726_CR59","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/IJMS23010348","volume":"23","author":"H Yamamoto","year":"2021","unstructured":"Yamamoto H, Hirasawa A (2021) Homologous recombination deficiencies and hereditary tumors. Int J Mol Sci 2022 23:348. https:\/\/doi.org\/10.3390\/IJMS23010348","journal-title":"Int J Mol Sci 2022"},{"key":"1726_CR60","doi-asserted-by":"publisher","first-page":"108286","DOI":"10.1016\/J.MRREV.2019.108286","volume":"782","author":"A Zebian","year":"2019","unstructured":"Zebian A, Shaito A, Mazurier F et al (2019) XPC beyond nucleotide excision repair and skin cancers. Mutat Research\/Reviews Mutat Res 782:108286. https:\/\/doi.org\/10.1016\/J.MRREV.2019.108286","journal-title":"Mutat Research\/Reviews Mutat Res"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-025-01726-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:07:20Z","timestamp":1771978040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-025-01726-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1007\/s13258-025-01726-8","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}